Charles River Laboratories International is a full service, non-clinical global drug development partner. Co. has laboratory animal medicine and science (research model technologies) to develop a portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP, that supports its clients from target identification through non-clinical development. Co. also provides a suite of products and services to support its clients' manufacturing activities, including its contract development and manufacturing organization business. Co. has three reporting segments: Research Models and Services, Discovery and Safety Assessment and Manufacturing Solutions. We show 58 historical shares outstanding datapoints in our CRL shares outstanding history coverage, used to compute CRL market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing CRL market cap history over the course of time is important for investors
interested in comparing CRL's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of CRL versus a peer is one thing; comparing
CRL market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like CRL can fluctuate over the course of history.
With this page we aim to empower investors researching CRL by allowing them to research the CRL market cap history. |
Free CRL Email Alerts:
Video: The Importance of Market Cap
